Filing Details
- Accession Number:
- 0001209191-14-023440
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-27 16:01:31
- Reporting Period:
- 2014-03-25
- Filing Date:
- 2014-03-27
- Accepted Time:
- 2014-03-27 16:01:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1201256 | S Michael Wyzga | C/O Akebia Therapeutics, Inc. 245 First Street, Suite 1100 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-25 | 1,500 | $17.00 | 1,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Purchase of shares in Issuer's directed share program in connection with the Issuer's initial public offering.
Billionaire Hedge Funds
